ConvergeHEALTH by Deloitte and Intermountain Healthcare Expand Real World Evidence Collaboration with Allergan to Focus on Women's Health

Aug 03, 2015, 10:33 ET from Deloitte

NEW YORK, Aug. 3, 2015 /PRNewswire/ -- ConvergeHEALTH by Deloitte is announcing that the global pharmaceutical company Allergan plc is expanding its year-long research collaboration with ConvergeHEALTH by Deloitte and Intermountain Healthcare to include women's health. 

This initiative will harness ConvergeHEALTH's OutcomesMiner analytics platform to generate real-world clinical insights in an effort to improve patient outcomes.

"We look forward to expanding our work with Allergan to address important scientific questions regarding the unmet needs of patients treated with intrauterine devices that can be answered from analyses of real-world data," said Dr. Nicole Hobbs, medical informatics director at Intermountain Healthcare. "Our goal is to optimize patient care by leveraging the insights we generate from this type of research."

The collaboration was launched in April 2014 to improve treatment protocols for respiratory diseases. Multiple projects are at various stages with initial results released at the American Thoracic Society's Annual Meeting.

"We are very encouraged with our association with ConvergeHEALTH and Intermountain and the near real- time insights we receive from OutcomesMiner," said Gavin Corcoran, chief medical officer, Allergan. 

In addition to working with ConvergeHEALTH, Allergan will continue to engage with Intermountain's Homer Warner Center for Informatics Research in conducting follow-on studies approved by an institutional review board. The Homer Warner Center is dedicated to the discovery and implementation of information technologies to enable data driven improvements to clinical care.

"Intermountain is a global leader in women's health and by collaborating with them we can generate insights that will help providers and patients choose the most appropriate treatments to best match their personalized needs," said Dr. Shailja Dixit, executive director, medical affairs, Allergan.

According to Brett Davis, principal, Deloitte Consulting LLP and general manager of ConvergeHEALTH by Deloitte, the expansion reflects ConvergeHEALTH's ability to help life sciences and health care organizations worldwide make advances in translational research, real-world evidence and personalized medicines. "Combining OutcomesMiner with Intermountain's clinical and informatics capabilities has the potential to generate insights that not only benefit patients but the entire health care system."

About Allergan
Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a unique, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing innovative branded pharmaceuticals, high-quality generic and over-the-counter medicines and biologic products for patients around the world.

Allergan markets a portfolio of best-in-class products that provide valuable treatments for the central nervous system, eye care, medical aesthetics, gastroenterology, women's health, urology, cardiovascular and anti-infective therapeutic categories, and operates the world's third-largest global generics business, providing patients around the globe with increased access to affordable, high-quality medicines. Allergan is an industry leader in research and development, with one of the broadest development pipelines in the pharmaceutical industry and a leading position in the submission of generic product applications globally.

With commercial operations in approximately 100 countries, Allergan is committed to working with physicians, health care providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives.

For more information, visit Allergan's website at www.allergan.com.

About ConvergeHEALTH
ConvergeHEALTH brings powerful, demonstrated analytics platforms and data models from Recombinant by Deloitte, advanced proprietary and open source analytics, content and benchmarks through collaboration with industry leaders and deep experiences from Deloitte's Life Sciences and Health Care consulting practice to help our clients survive and thrive in the new paradigm of value-based, personalized medicine. For more information, visit www.converge-health.com.

About Intermountain Healthcare
Intermountain Healthcare is a Utah-based, not-for-profit system of 22 hospitals, 185 clinics, a Medical Group with some 1,300 employed physicians, a health plans division called SelectHealth, and other health services. Helping people live the healthiest lives possible, Intermountain is widely recognized as a leader in transforming healthcare through high quality and sustainable costs. For more information about Intermountain, visit intermountainhealthcare.org, read our blogs at intermountainhealthcare.org/blogs, connect with us on Twitter at twitter.com/intermountain and on Facebook at facebook.com/intermountain.

As used in this document, "Deloitte" means Deloitte Consulting LLP, a subsidiary of Deloitte LLP.  Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.

Logo - http://photos.prnewswire.com/prnh/20120803/MM52028LOGO-a  

SOURCE Deloitte



RELATED LINKS

http://www.deloitte.com/us